Ursodeoxycholic acid for liver regeneration after transplant
Treatments studied
Part of Digestive system clinical trials.
This trial tests whether giving ursodeoxycholic acid (a bile acid medication) after a living donor liver transplant helps the new liver grow and work better. It may help your liver recover more quickly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are receiving a liver transplant from a living donor (not a deceased donor).
- You are not allergic to ursodeoxycholic acid.
- You have not taken ursodeoxycholic acid within the month before your transplant.
- You are not having an emergency transplant.
- You are not receiving a right posterior or left lateral segment graft.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the donor's liver grows back after donating a part of it for a living donor liver transplant. If you have donated a part of your liver between 2004 and 2026, joining could help doctors learn more about liver healing.
This study looks at living donor liver transplant care and follows patients for about 3 years to see how they do over time. If you had (or are scheduled for) a living donor liver transplant and can be followed long-term, this trial may be able to collect your outcomes.
This trial tests whether a liver transplant from a living donor can help people with a certain bile duct cancer that hasn't spread. It is for patients whose cancer is stable or smaller after chemotherapy.
This trial looks at whether slowly reducing UDCA (a medication for primary biliary cholangitis) is safe and still helpful in people whose liver tests have improved. It may help some patients avoid higher doses if their disease is well controlled.
This trial looks at liver transplant for people with advanced intrahepatic cholangiocarcinoma (a bile duct cancer inside the liver) when the cancer is not safely removable and stays controlled. It may help some patients live longer and with better quality of life by replacing the diseased liver—if strict safety and disease-stability requirements are met.
This trial is testing a new way to see how well patients do after a liver transplant. It includes people with severe cirrhosis, other end-stage liver diseases, or liver cancer.
Hear when a new Chronic Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.